Novartis AG - Guide to Insomnia

Stifel Nicolaus equities research analysts gave shares of Celgene (NASDAQ: CELG) a new “buy” rating with a price target of $71.00 in a research...

With 26 million people unable to find full-time jobs, Americans are outraged by disparities in pay between executives and average workers as real...

Fears about the fate of the Euro, European Union and possible austerity plans have shaken the global markets. The Euro itself as represented by the...

With the threat of swine flu in 2009 came vaccine shortages, long lines at distribution centers, and frustrated consumers. New technologies for...

Recognizing the strong commercial opportunities for its services in Europe, Caris Life Sciences , a leading biosciences company focused on driving...

I love cash. As an investor, nothing makes me happier than a company that returns money to shareholders, rather than spending it recklessly on a...

ULURUInc.(NYSE Alternext: ULU)announced today that it has signed a worldwide distribution agreement appointing Novartis the exclusive distributor...

Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published Thursday in the journal Science.The drug could be ready for clinical trials as ...

The Swiss pharmaceutical group Novartis plans to build Latin America's first vaccine factory in Brazil with an investment of 300 to 500 million dollars, the financial daily Valor reported Thursday.The plant, which will be located near the northeastern cit

ZURICH (Reuters) - Swiss drugmaker Novartis AG is pushing ahead with its contentious buyout of Alcon minority shareholders after completing its acquisition of stock from Nestle to get control of the U.S. eyecare group.Novartis, which now holds a 77 per

Topic: Novartis AG

Stifel Nicolaus Gives Celgene (NASDAQ: CLEG) a “Buy” Rating

How to Handle CEO Pay Before Dodd-Frank Hits

European Value Buys (VGK, ABB, NSGRY, SI, TOT)

Research and Markets: Introducing 2010 Report 'Influenza Vaccine Manufacturing: Can New Technologies Open the Production Bottleneck?'

Caris Life Sciences Staffs for Aggressive European Growth

Dividends Aren' Drug Companies

ULURU Inc. Announces the Appointment of Novartis Animal Health as...

Promising new one-dose malaria drug discovered

Novartis to build vaccine plant in Brazil

Novartis to push ahead with disputed Alcon buyout

Photo Gallery

Video Gallery

Follow this Topic with...